^
Association details:
Biomarker:No biomarker
Cancer:Colon Cancer
Drug:Cyramza (ramucirumab) (VEGFR-2 inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Colon Cancer...SYSTEMIC THERAPY FOR ADVANCED OR METASTATIC DISEASE - CHEMOTHERAPY REGIMENS...FOLFIRI + ramucirumab
Secondary therapy:
FOLFIRI